HeartBeat.bio

We use the worldwide first self-organizing human heart organoids to reinvent cardiac drug discovery.

HeartBeat.bio is a recently founded drug discovery company focusing on the development of a high-throughput 3D screening platform tackeling cardiomyopathies, cardiotoxicity and heart failure. Our core technology is based on the world-wide first, self-organizing cardiac organoids (cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.

YouTube

Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren

Video laden

Persönliches Profil